Baxter International Inc.
Baxter International Inc. (BAX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bax · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Baxter International Inc. (BAX) measures how much investors pay for each dollar of the company's trailing earnings. BAX's current PE ratio of N/A is calculated by dividing its stock price of $19.38 by its TTM earnings per share of -$2.13.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 17 fiscal years · Front-end computedMinQ1 · 25%11.4x
MedianQ3 · 75%58.3x
Max
At N/A, BAX's current P/E is lower than in 0% of its annual fiscal year readings over the past 17 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Baxter International Inc.You BAX | $10.0B | N/A | — | -$2.13 |
 AptarGroup, Inc. ATR | $7.2B | 20.41x | -19.4% | $5.97 |
 Avantor, Inc. AVTR | $6.3B | N/A | — | -$0.78 |
 Bio-Rad Laboratories, Inc. BIO | $8.0B | 10.87x | -57.1% | $27.87 |
 DaVita Inc. DVA | $12.3B | 13.10x | -48.3% | $8.67 |
 Hims & Hers Health, Inc. HIMS | $5.8B | 56.90x | +124.7% | $0.57 |
 Masimo Corporation MASI | $9.4B | N/A | — | -$2.83 |
Industry Average 4 peers with valid PE | — | 25.32x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.87 | — | |
2024-12-31 FY2024 | — | $-1.27 | — | |
2023-12-31 FY2023 | 7.37x | $5.25 | — | |
2022-12-31 FY2022 | — | $-4.83 | — | |
2021-12-31 FY2021 | 33.56x | $2.56 | -9.4% | |
2020-12-31 FY2020 | 37.06x | $2.17 | -12.8% | |
2019-12-31 FY2019 | 42.52x | $1.97 | +87.0% | |
2018-12-31 FY2018 | 22.73x | $2.90 | -61.0% | |
2017-12-31 FY2017 | 58.30x | $1.11 | +1095.7% | |
2016-12-31 FY2016 | 4.88x | $9.09 | -77.3% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Baxter International Inc. (BAX) measures how much investors pay for each dollar of the company's trailing earnings. BAX's current PE ratio of N/A is calculated by dividing its stock price of $19.38 by its TTM earnings per share of -$2.13.
Frequently asked questions
BAX pe ratio · 6 questionsBAX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $19.38 and TTM EPS of -$2.13. Data sourced from Financial Modeling Prep via BAX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Baxter International Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08